Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Uni-Bio Science Group Ltd
0690Current price
0.076 HKD
+0.004 HKD (+5.56%)
Last closed
0.073 HKD
Company
www.uni-bioscience.com
ISIN
KYG9198H1406
Sector
Healthcare
Industry
Biotechnology
Exchange
Hong Kong Stock Exchange
Capitalization
443 135 597 HKD
Yield for 12 month
+43.40 %
1Y
3Y
5Y
10Y
15Y
0690
Uni-Bio Science Group Limited, an investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People's Republic of China. It operates in Chemical Pharmaceutical Products, Biological Pharmaceutical Products, and Pipeline Products. The company provides GeneTime, a prescription biological drug for wound healing; GeneSoft, a therapeutic drug for dry eye syndrome, corneal damage, and post-operative healing; Pinup, a voriconazole tablet to treat severe fungal infections; and Boshutai, a small molecule drug to treat diabetes. It is also developing prescription drugs, including rExendin-4 (Uni-E4) for Type 2 diabetes; and rhPTH 1-34 (Uni-PTH) for the treatment of osteoporosis in postmenopausal women, as well as Uni-GLP, a GLP-1 agent for the treatment of Type 2 diabetes. In addition, the company is involved in the distribution of hydrogel wound dressing for post-skin injury and minimally invasive surgery wound healing. Uni-Bio Science Group Limited was incorporated in 2001 and is headquartered in Sha Tin, Hong Kong. Address: No. 20 Science Park East Avenue, Sha Tin, Hong Kong
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
–P/E ratio
3.6Dividend Yield
–Current Year
+484 308 134 HKD
Last Year
+439 943 680 HKD
Current Quarter
+249 721 664 HKD
Last Quarter
–
Current Year
+392 485 839 HKD
Last Year
+334 599 833 HKD
Current Quarter
+198 685 852 HKD
Last Quarter
–
Key Figures 0690
1 year
3 years
5 years
10 years
EBITDA
123 551 442 HKD
Operating Margin TTM
PE Ratio
3.6
Return On Assets TTM
17.05 %
PEG Ratio
–
Return On Equity TTM
36.79 %
Wall Street Target Price
–
Revenue TTM
507 970 107 HKD
Book Value
0.051 HKD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
9.5 %
Dividend Yield
–
Gross Profit TTM
334 599 830 HKD
Earnings per share
–
Diluted Eps TTM
–
Most Recent Quarter
II 2023
Quarterly Earnings Growth YOY
76.6 %
Profit Margin
19.44 %
Dividend Analytics 0690
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 0690
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
22.08.2007
Forward Annual Dividend Yield
–
Last Split Factor
1:10
Payout Ratio
–
Last Split Date
31.08.2009
Dividend Date
–
Stock Valuation 0690
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
3.6
Forward PE
–
Enterprise Value Revenue
0.741
Price Sales TTM
0.8724
Enterprise Value EBITDA
3.5993
Price Book MRQ
1.7485
Financials 0690
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 0690
For 52 weeks
0.041 HKD
0.11 HKD
50 Day MA
0.058 HKD
Shares Short Prior Month
–
200 Day MA
0.071 HKD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart